In focus
Latest feed
Cytokinetics' Myqorzo Secures Landmark FDA Approval, Reshaping HCM Treatment Landscape
Navigating the Nuances of Cytokinetics: December's Catalyst and the Investment Conundrum
The Unraveling of a Biotech Dream: When Investor Optimism Meets Harsh Reality
The Echo of Disappointment: When Promises Fade for Cytokinetics Investors
